I agree that this site is using cookies. You can find further informations here.
X
Vekemans, Johan
259  results:
Search for persons X
?
1

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): ..:

Kulkarni, Prasad S. ; Padmapriyadarsini, Chandrasekaran ; Vekemans, Johan...
Human Vaccines & Immunotherapeutics.  20 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
2

What is next for BCG revaccination to prevent tuberculosis?:

White, Richard G ; Fiore-Gartland, Andrew J ; Hanekom, Willem A...
The Lancet Respiratory Medicine.  12 (2024)  3 - p. e7-e8 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Measuring indirect transmission-reducing effects in tubercu..:

Nelson, Kristin N ; Churchyard, Gavin ; Cobelens, Frank...
The Lancet Microbe.  4 (2023)  8 - p. e651-e656 , 2023
Link: https://doi.org/10.1016/..
 
?
4

An Aspiration to Radically Shorten Phase 3 Tuberculosis Vac..:

Hill, Philip C ; Cobelens, Frank ; Martinez, Leonardo...
The Journal of Infectious Diseases.  , 2023
Link: https://doi.org/10.1093/..
 
?
5

Immunogenicity and safety of AZD2816, a beta (B.1.351) vari..:

Ramasamy, Maheshi N ; Kelly, Elizabeth J ; Seegobin, Seth...
The Lancet Microbe.  4 (2023)  11 - p. e863-e874 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) agai..:

Asano, Michiko ; Okada, Hiroshi ; Itoh, Yohji...
International Journal of Infectious Diseases.  114 (2022)  - p. 165-174 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Leveraging Vaccines to Reduce Antibiotic Use and Prevent An..:

Vekemans, Johan ; Hasso-Agopsowicz, Mateusz ; Kang, Gagandeep...
Clinical Infectious Diseases.  73 (2021)  4 - p. e1011-e1017 , 2021
Link: https://doi.org/10.1093/..
 
?
8

A phase 2/3, participant-blind, observer-blind, randomised,..:

Kulkarni, Prasad S ; Padmapriyadarsini, Chandrasekaran ; Vekemans, Johan...
eClinicalMedicine.  42 (2021)  - p. 101218 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Meeting report: WHO consultation on malaria vaccine develop..:

Vekemans, Johan ; Schellenberg, David ; Benns, Sarah..
Vaccine.  39 (2021)  22 - p. 2907-2916 , 2021
Link: https://doi.org/10.1016/..
 
?
10

Correlates of protection against symptomatic and asymptomat..:

Feng, Shuo ; Phillips, Daniel J. ; White, Thomas...
Nature Medicine.  27 (2021)  11 - p. 2032-2040 , 2021
Link: https://doi.org/10.1038/..
 
?
11

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a P..:

de Graaf, Hans ; Payne, Ruth O. ; Taylor, Iona...
Frontiers in Immunology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
12

Long-term immunogenicity and immune memory response to the ..:

Valéa, Innocent ; Adjei, Samuel ; Usuf, Effua...
Human Vaccines & Immunotherapeutics.  16 (2020)  6 - p. 1464-1470 , 2020
Link: https://doi.org/10.1080/..
 
?
13

Building momentum for malaria vaccine research and developm..:

Chitnis, Chetan E. ; Schellenberg, David ; Vekemans, Johan...
Malaria Journal.  19 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
14

Preferred product characteristics for therapeutic vaccines ..:

Vekemans, Johan ; Brennan, Michael James ; Hatherill, Mark...
Vaccine.  38 (2020)  2 - p. 135-142 , 2020
Link: https://doi.org/10.1016/..
 
?
15

A Phase IIa Controlled Human Malaria Infection and Immunoge..:

Moon, James E ; Ockenhouse, Christian ; Regules, Jason A...
The Journal of Infectious Diseases.  222 (2020)  10 - p. 1681-1691 , 2020
Link: https://doi.org/10.1093/..
 
1-15